Dapagliflozin clinical trials
Also written Forxiga, Farxiga, BMS-512148 and BR3006.
How each study uses dapagliflozin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the dapagliflozin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 8 Jan 2014 · FARXIGA · NDA 202293 (FDA, Drugs@FDA)
- European Union
- 11 Nov 2012 · Forxiga · EMEA/H/C/002322 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Studies by the year they started
482 studies that test it; most in 2022 (54); 3 more planned to start later
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 8 |
| 2009 | 12 |
| 2010 | 13 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 14 |
| 2015 | 27 |
| 2016 | 29 |
| 2017 | 21 |
| 2018 | 15 |
| 2019 | 26 |
| 2020 | 33 |
| 2021 | 43 |
| 2022 | 54 |
| 2023 | 41 |
| 2024 | 48 |
| 2025 | 42 |
| 2026 | 36 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 126 · Other 359
AstraZeneca (106) · The University of Texas Health Science Center at San Antonio (11) · Mansoura University (9) · University of Guadalajara (6) · Tanta University (5) · Ain Shams University (5) · University of Campinas, Brazil (5) · Assiut University (5)
Often tested with
Tested in the same studies.
Metformin (27) · Empagliflozin (20) · Saxagliptin (15) · Sitagliptin (10) · Semaglutide (9) · Pioglitazone (9) · ZD4054 (7) · Exenatide (6)
Related medicines
As reviewed, each with the page that says it.
- One of SGLT2 inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 4 phase 3 studies under way
Dapagliflozin is the comparator. A study of two new drugs counts under both.
- 1Enavogliflozin · Daewoong Pharmaceutical Co. LTD.
- 1HDM1002 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · next primary completion Feb 2027
Reaching primary completion within a year · 37, 11 in phase 3
Studies that test dapagliflozin, phase 3 first.
- Nov 2026Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial FibrillationPhase 2/3 · Chang Gung Memorial Hospital
- Dec 2026CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIALPhase 3 · 4th Military Clinical Hospital with Polyclinic, Poland
- Jan 2027Epicardial Cardiac Fat-CT (EPIC-CT)Phase 3 · Instituto Mexicano del Seguro Social
- Feb 2027Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)Phase 3 · AstraZeneca
- Apr 2027Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)Phase 3 · University of Oklahoma
- Apr 2027Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary SyndromePhase 2/3 · Tanta University
- May 2027"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes"Phase 3 · Chittagong Medical College
- Jun 2027Dapagliflozin in STEMIPhase 3 · Ottawa Heart Institute Research Corporation
- Jul 2027The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKDPhase 3 · University Medical Center Groningen
- Jul 2027"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"Phase 2/3 · Beni-Suef University
Studies
Open first, then newest update. How each study uses dapagliflozin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 485
- Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 FibrosisRecruitingPhase 4Madrigal Pharmaceuticals, Inc.NCT07848191Written as FARXIGA/dapagliflozin
- Validation & Intervention Testing for Aging, Longevity and HealthspanNot yet recruitingPhase 2The University of Texas Health Science Center at San AntonioNCT07923630Written as Dapagliflozin 10Mg Oral Tablet
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruitingPhase 3AstraZenecaNCT06742723Written as Baxdrostat/dapagliflozin
- Dapagliflozin in Active Lupus NephritisRecruitingPhase 4Brigham and Women's HospitalNCT07323524Written as Dapagliflozin (10Mg Tab) along with standard medical therapy
- Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung AdenocarcinomaRecruitingEarly Phase 1Jonsson Comprehensive Cancer CenterNCT07235280Written as Dapagliflozin Propanediol
- Dapagliflozin for Long COVID SyndromeNot yet recruitingPhase 3Ottawa Heart Institute Research CorporationNCT06907251Written as Dapagliflozin (DAPA)
- CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM SyndromeRecruitingPhase 4Shenyang Northern HospitalNCT07351643Written as Dapagliflozin
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusRecruitingPhase 3AstraZenecaNCT07662109Written as Dapagliflozin
- Efficacy and Safety of Dapagliflozin as an Adjunct to Conventional Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid ArthritisNot yet recruitingPhase 1/2Tanta UniversityNCT07901309Written as Dapagliflozin (10mg Tab)
- Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status TrialRecruitingPhase 4The University of Hong KongNCT06668389Written as SGLT2 inhibitor (Dapagliflozin 10mg)
- Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate CancerRecruitingPhase 2Yung NANCT07310433Written as Dapagliflozin (10mg Tab)
- Dapagliflozin in Patients With Non-Obstructive Hypertrophic Cardiomyopathy: A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialNot yet recruitingPhase 4Yonsei UniversityNCT07897500Written as Dapagliflozin 10mg
- Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCINot yet recruitingPhase 2Al-Azhar UniversityNCT07898709Written as dapagliflozin
- Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Disease in Patients With Insulin ResistanceNot yet recruitingPhase 4Sherihan AboElyazed Mohamed KhalilNCT07891234Written as Dapagliflozin 5Mg Tab
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinRecruitingPhase 3AstraZenecaNCT06677060Written as Baxdrostat and dapagliflozin
- Phase 3 Clinical Trial With Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult PatientsRecruitingPhase 3University Hospital GoettingenNCT05944016Written as Dapagliflozin
- Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMIRecruitingNot applicableMohammad Hussien Tantawy SolimanNCT06009874Written as Dapagliflozin 10mg Tab
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Farxiga
- STunning in Acute Myocardial Infarction - BASRecruitingPhase 4Vastra Gotaland RegionNCT06562582Written as Dapagliflozin Oral Product
- Evaluation of Dapagliflozin and Empagliflozin as Adjunctive Therapy to Methotrexate in Patients With Rheumatoid ArthritisNot yet recruitingPhase 2Al-Azhar UniversityNCT07864688Written as Dapagliflozin
See all 485 studies that test dapagliflozin →
Given beside what is tested · 43 — dapagliflozin is usual care or a partner of the new treatment
- Adding Acetazolamide on Top of SGLT2 Inhibition in Persons With Type 2 DiabetesNot yet recruitingPhase 2University Health Network, TorontoNCT07902726Written as Dapagliflozin 10mg
- Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes MellitusRecruitingPhase 4Anemia Working Group RomaniaNCT06281899Written as Dapagliflozin 10 mg Tab
- dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized EvaluationNot yet recruitingPhase 2University Medical Center GroningenNCT06072326Written as Dapagliflozin (Forxiga®)
- SGLT2i, Pioglitazone, and Ketone Production in T1DRecruitingPhase 3The University of Texas Health Science Center at San AntonioNCT07056699Written as Dapagliflozin 10mg Tab
- Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)RecruitingPhase 1Washington University School of MedicineNCT05521984Written as Dapagliflozin
- DP-DCT 1.0:A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT PlatformNot yet recruitingNot applicableThe Third Xiangya Hospital of Central South UniversityNCT07595289Written as Dapagliflozin (10mg Tab)
- POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart FailureNot yet recruitingPhase 2/3Hospital de Clinicas de Porto AlegreNCT07469722Written as Dapagliflozin (10mg Tab)
- A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 DiabetesRecruitingPhase 4Boryung Pharmaceutical Co., LtdNCT06972732Written as Dapagliflozin/Pioglitazone
- A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA NephropathyCompletedPhase 3Travere Therapeutics, Inc.NCT03762850Written as Dapagliflozin
- Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation in Women With Polycystic Ovarian SyndromeCompletedPhase 4Beni-Suef UniversityNCT07589075Written as Dapagliflozin 10 MG Oral Tablet [Farxiga]
- Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian SyndromeCompletedPhase 3Beni-Suef UniversityNCT06405178Written as Dapagliflozin
- Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart ValvesCompletedPhase 2Kafrelsheikh UniversityNCT07610174Written as Dapagliflozin (10mg Tab)
- Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 DrugsActive, not recruitingNot applicableNazarbayev UniversityNCT07303556Written as dapagliflozin, empagliflozin, metformin
- Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic VolunteersCompletedNot applicableAl-Balqa Applied UniversityNCT06241638Written as Dapagliflozin 10mg Tab
- A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal ImpairmentTerminatedPhase 1AstraZenecaNCT06639087Written as Dapagliflozin
- The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary HypertensionCompletedNot applicableFayoum UniversityNCT06778330Written as Dapagliflozin (DAPA)
- A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese ParticipantsCompletedPhase 1AstraZenecaNCT06651021Written as balcinrenone/dapagliflozin
- A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseTerminatedPhase 2AstraZenecaNCT04492722Written as Dapagliflozin 10 mg
- Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)CompletedPhase 2AstraZenecaNCT04724837Written as Dapagliflozin
- A Phase 2b Diabetic Kidney Disease StudyCompletedPhase 2AstraZenecaNCT04170543Written as Dapagliflozin
Showing 20 of 43.
As the comparator · 23 — what is tested is compared with dapagliflozin
- A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 DiabetesRecruitingPhase 4Boryung Pharmaceutical Co., LtdNCT06972732Written as Dapagliflozin/Pioglitazone
- A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07082114Written as Dapagliflozin (DAPA)
- Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial FibrillationNot yet recruitingPhase 1Assiut UniversityNCT06759909Written as Dapagliflozin (DAPA)
- Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure PatientsRecruitingPhase 3Helwan UniversityNCT06535529Written as Dapagliflozin 10mg
- The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 DiabetesRecruitingPhase 4Sun Yat-sen UniversityNCT06127433Written as Dapagliflozin
- Efficacy and Safety of LID104 in the Treatment of Type II Diabetes MellitusNot yet recruitingPhase 3EMSNCT05886088Written as Dapagliflozin
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminCompletedPhase 3Eli Lilly and CompanyNCT06192108Written as Dapagliflozin
- Comparing The Effect Of Empagliflozin With Dapagliflozin In Reducing Proteinuria In Diabetic Patients With Chronic Kidney Disease With eGFR More Than 45ml/Min/1.73m²CompletedNot applicableLahore General HospitalNCT07866235Written as Dapagliflozin
- Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With MetforminCompletedPhase 3Shenzhen HighTide Biopharmaceutical Ltd.NCT06415773Written as Dapagliflozin
- A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With MetforminCompletedPhase 3Shandong Suncadia Medicine Co., Ltd.NCT06589765Written as dapagliflozin tablet
- A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyCompletedPhase 4Celltrion Pharm, Inc.NCT03499704Written as Dapagliflozin
- Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DMCompletedPhase 4AstraZenecaNCT06327815Written as Dapagliflozin tablets and Metformin HCl extended-release tablets
- Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedPhase 4Dong-A ST Co., Ltd.NCT05743907Written as Forxiga
- The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on MetforminActive, not recruitingPhase 3Daewoong Pharmaceutical Co. LTD.NCT05505994Written as Dapagliflozin
- Dapagliflozin in Patients With Critical IllnessCompletedPhase 3Hospital Israelita Albert EinsteinNCT05558098Written as Dapagliflozin 10mg Tab
- A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 DiabetesCompletedPhase 2Youngene Therapeutics Inc., Ltd.NCT04956263Written as Dapagliflozin
- Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.WithdrawnPhase 3EMSNCT03766750Written as Forxiga
- Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic NephropathyStatus unknownNot applicableThe First Affiliated Hospital of Dalian Medical UniversityNCT05418465Written as Dapagliflozin
- A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and DapagliflozinStatus unknownPhase 4Kyung Hee University Hospital at GangdongNCT04706637Written as Dapagliflozin
- Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM WomenCompletedPhase 3Woman'sNCT02338193Written as DAPA
Showing 20 of 23.
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting2
Results posted1
Newly registered7
- Natriuresis With Acetazolamide or SGLT2 Inhibitors Added to Intravenous Loop Diuretics in Decompensated Heart FailureNov 9, 2026NCT07926958
- Validation & Intervention Testing for Aging, Longevity and HealthspanNov 6, 2026NCT07923630
- Efficacy and Safety of Dapagliflozin as an Adjunct to Conventional Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid ArthritisOct 28, 2026NCT07901309
- Dapagliflozin in Patients With Non-Obstructive Hypertrophic Cardiomyopathy: A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialOct 27, 2026NCT07897500
- Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCIOct 27, 2026NCT07898709
Show 2 moreShow fewer
Codes
What other systems call dapagliflozin · ClinicalTrials.gg INT005279
- MeSH (NLM) C529054dapagliflozinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 1ULL0QJ8UCDAPAGLIFLOZINConfirmed FDA, NLM, Wikidata
- RxNorm 1488564Confirmed FDA, Wikidata
- Wikidata Q409898dapagliflozinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C78126DapagliflozinOne source FDA
- DrugBank DB06292One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C529054 | dapagliflozin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 1ULL0QJ8UC | DAPAGLIFLOZIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1488564 | — | Confirmed FDA, Wikidata |
| Wikidata | Q409898 | dapagliflozin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C78126 | Dapagliflozin | One source FDA |
| DrugBank | DB06292 | — | One source Wikidata |
Also registered as dapagliflozin propanediol (UNII 887K2391VH · RxNorm 1486966).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.